Levocarnitine in Treating Fatigue in Cancer Patients

Completed · Phase 3 · Has a placebo group

Conditions studied: Fatigue, Unspecified Adult Solid Tumor, Protocol Specific

In brief

RATIONALE: Levocarnitine may help improve energy levels in cancer patients. PURPOSE: This randomized phase III trial is studying how well levocarnitine works compared to a placebo in treating fatigue in cancer patients.

Key facts

Study ID
NCT00091169
Run by
ECOG-ACRIN Cancer Research Group
People needed
376
Starts
2005-12-16
Expected to finish
2011-05-01
Last updated by the study team
2023-07-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.